感染性心内膜炎合并主动脉根部脓肿的手术结局
该回顾性队列纳入1996至2017年336例因感染性心内膜炎行主动脉瓣或根部置换的患者,比较有根部脓肿(n=179)与无脓肿(n=157)的围术期结局与长期生存。脓肿组手术死亡率8.4%对3.8%(P=.11),10年生存率41%对43%(P=.35),再手术率5.9%对7.9%,但脓肿组机械通气与ICU停留更长;根部脓肿是全因死亡独立危险因素(HR 1.42,95%CI 1.02-1.96)。
要点
- 根部脓肿不显著增加手术死亡率,但延长机械通气与ICU停留。
- 两组10年生存率与再手术率相似。
- 彻底清创是关键,带支架与无支架生物瓣均可作为管道。
核心结论
- 彻底广泛清创是成功治疗活动性心内膜炎合并根部脓肿的关键。
- 带支架和无支架生物瓣均是治疗根部脓肿的有效管道。
研究设计与样本
- 1996至2017年连续336例因感染性心内膜炎行主动脉瓣或根部置换的患者,其中根部脓肿179例、无脓肿157例。
- 数据来自胸外科医师学会数据仓库、病历回顾、患者调查及国家死亡指数。
主要发现
- 脓肿组充血性心力衰竭患病率显著更低,人工瓣膜心内膜炎比例更高。
- 脓肿组主动脉根部置换更多,体外循环与交叉钳夹时间更长。
- 手术死亡率脓肿组8.4%、无脓肿组3.8%(P=.11)。
- 脓肿组机械通气时间与ICU停留更长。
- 10年生存率脓肿组41%、无脓肿组43%(P=.35),10年再手术率5.9%对7.9%。
关键数值与推荐
- 全因死亡危险因素:年龄>70岁(HR 2.85,95%CI 1.55-5.24)。
- 根部脓肿(HR 1.42,95%CI 1.02-1.96)、静脉吸毒(HR 1.81,95%CI 1.13-2.89)。
- 充血性心力衰竭(HR 1.72,95%CI 1.22-2.42)、需透析的肾衰竭(HR 3.26,95%CI 2.30-4.64)。
- 肝病(HR 3.04,95%CI 1.65-5.60)、术后脓毒症(HR 3.00,95%CI 1.30-6.93)。
临床怎么用
- 对活动性心内膜炎合并根部脓肿行手术时应彻底广泛清创。
- 可选用带支架或无支架生物瓣作为根部管道。
- 术后需关注延长机械通气与ICU停留风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the influence of an aortic root abscess on perioperative outcomes and long-term survival in patients with active infectious endocarditis that was treated surgically. METHODS: From 1996 to 2017, 336 consecutive patients were treated with aortic valve or root replacement for infective endocarditis, including patients with (n = 179) or without (n = 157) a root abscess. Data were obtained from the Society of Thoracic Surgeons data warehouse, through chart review, patient surveys, and National Death Index data. RESULTS: Demographic characteristics were similar between groups except the root abscess group had a significantly lower prevalence of congestive heart failure and higher rates of prosthetic valve endocarditis. The abscess group had significantly more aortic root replacements as well as longer cardiopulmonary bypass and crossclamp times. Operative mortality was 8.4% and 3.8% (P = .11) for the abscess and no abscess groups, respectively. Nevertheless, the root-abscess group had prolonged ventilation and longer intensive care unit stays. Kaplan-Meier survival was similar between root abscess and no abscess groups (10-year survival 41% vs 43%; P = .35). Significant risk factors for all-time mortality included age greater than 70 (hazard ratio [HR], 2.85; 95% confidence interval [CI], 1.55, 5.24), the presence of a root abscess (HR, 1.42; 95% CI, 1.02, 1.96), intravenous drug use (HR, 1.81; 95% CI, 1.13, 2.89), congestive heart failure (HR, 1.72; 95% CI, 1.22, 2.42), renal failure requiring dialysis (HR, 3.26; 95% CI, 2.30, 4.64), liver disease (HR, 3.04; 95% CI, 1.65, 5.60), and postoperative sepsis (HR, 3.00; 95% CI, 1.30, 6.93). The 10-year rate of reoperation was also similar between groups (5.9% vs 7.9%). CONCLUSIONS: Thorough and extensive debridement is critical for successful treatment of active endocarditis with root abscess. Bioprosthetic stented and stentless valves are valid conduits to treat endocarditis with root abscess.
引用
- Yang B, Caceres J, Farhat L, et al. Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes. J Thorac Cardiovasc Surg. 2020. PMID: 32418636. doi:10.1016/j.jtcvs.2019.12.140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。